Vascular endothelial growth factor (VEGF) &#8212; part 1: in physiology and pathophysiology

Dariusz Kajdaniuk; Bogdan Marek; Halina Borgiel-Marek; Beata Kos-Kudła

Vol 62, No 5 (2011)

Review paper

Submitted: 2013-02-15

Published online: 2011-11-08

View PDF

Download PDF file

Get Citation

Vascular endothelial growth factor (VEGF) — part 1: in physiology and pathophysiology

Dariusz Kajdaniuk, Bogdan Marek, Halina Borgiel-Marek, Beata Kos-Kudła

Endokrynol Pol 2011;62(5):444-455.

Vol 62, No 5 (2011)

Review Article

Submitted: 2013-02-15

Published online: 2011-11-08

Abstract

Angiogenesis is an important component of many physiological processes, such as the female sexual cycle, placenta formation, the processes of growth and differentiation of tissues, and reparative processes including wound healing, fracture repair, and liver regeneration. The formation of new blood vessels during angiogenesis and vasculogenesis allows the growth and functioning of multicellular organisms. Pathological angiogenesis most commonly occurs in ischaemic, inflammatory and neoplastic diseases. Conditions in the pathogenesis of which angiogenesis plays an important role are sometimes labelled angiogenic diseases. To date, a number of pro-and anti-angiogenic factors have been defined. VEGF is the only specific mitogen for endothelial cells. It stimulates their growth and inhibits apoptosis, increases vascular permeability in many tissues, promotes vasculogenesis and angiogenesis. VEGF signalling activity in relation to the cell is dependent on having its specific membrane receptors (Flt-1, KDR, Flt-4). Angiogenesis plays a protective role in ischaemic heart disease and myocardial infarction. Angiogenesis extends life for patients after a stroke. Most of the facts about physiological angiogenesis are derived from studies into liver regeneration as a result of an acute injury or partial hepatectomy. Pathological hepatic angiogenesis occurs in the course of inflammation, fibrosis, hypoxia, and during tumourogenesis. There is interesting data relating to liver steatosis and obesity. (Pol J Endocrinol 2011; 62 (5): 444–455)

Abstract

Angiogenesis is an important component of many physiological processes, such as the female sexual cycle, placenta formation, the processes of growth and differentiation of tissues, and reparative processes including wound healing, fracture repair, and liver regeneration. The formation of new blood vessels during angiogenesis and vasculogenesis allows the growth and functioning of multicellular organisms. Pathological angiogenesis most commonly occurs in ischaemic, inflammatory and neoplastic diseases. Conditions in the pathogenesis of which angiogenesis plays an important role are sometimes labelled angiogenic diseases. To date, a number of pro-and anti-angiogenic factors have been defined. VEGF is the only specific mitogen for endothelial cells. It stimulates their growth and inhibits apoptosis, increases vascular permeability in many tissues, promotes vasculogenesis and angiogenesis. VEGF signalling activity in relation to the cell is dependent on having its specific membrane receptors (Flt-1, KDR, Flt-4). Angiogenesis plays a protective role in ischaemic heart disease and myocardial infarction. Angiogenesis extends life for patients after a stroke. Most of the facts about physiological angiogenesis are derived from studies into liver regeneration as a result of an acute injury or partial hepatectomy. Pathological hepatic angiogenesis occurs in the course of inflammation, fibrosis, hypoxia, and during tumourogenesis. There is interesting data relating to liver steatosis and obesity. (Pol J Endocrinol 2011; 62 (5): 444–455)

Full Text:
View PDF Download PDF file

Get Citation

Keywords

VEGF; angiogenesis; physiology; pathophysiology; KDR; Flt-1; liver; cancer; neoplasm; growth factor

About this article

Title

Vascular endothelial growth factor (VEGF) — part 1: in physiology and pathophysiology

Journal

Endokrynologia Polska

Issue

Vol 62, No 5 (2011)

Article type

Review paper

Pages

444-455

Published online

2011-11-08

Page views

1351

Article views/downloads

2711

Bibliographic record

Endokrynol Pol 2011;62(5):444-455.

Keywords

VEGF
angiogenesis
physiology
pathophysiology
KDR
Flt-1
liver
cancer
neoplasm
growth factor

Authors

Dariusz Kajdaniuk
Bogdan Marek
Halina Borgiel-Marek
Beata Kos-Kudła